Evolution of the Average Target: RH

Data source: RH(RH)

Evolution of the Target Price: RH

Data source: RH(RH)

Changes in Analyst Recommendations: RH

Data source: RH(RH)
3df88c756ffff5b3288.ElJxUjEVWu5AapCocd1jtw69WF1WRTId34d40Ik3wYc.YwgSOlRaAqcVXObmA-0Q2X6POmU4I0B3nsoQ4v17mexKET5lRlMRsRpHyQ~a3bd23ff739eafb12b7e2f4373052173
09-11 UBS Adjusts Price Target on RH to $154 From $155, Keeps Neutral Rating MT
09-11 BofA Securities Adjusts RH Price Target to $114 From $156, Maintains Underperform Rating MT
07-08 Goldman Sachs Upgrades RH to Neutral From Sell, Lifts Price Target to $155 From $86 MT
06-09 RH Q1 Unlikely to Show Business Inflection, UBS Says MT
06-09 UBS Adjusts Price Target on RH to $155 From $160, Maintains Neutral Rating MT
04-02 Guggenheim Lowers Price Target on RH to $200 From $275, Keeps Buy Rating MT
04-01 RH Facing Near-Term Challenges From Execution, Supply Chain Issues, Morgan Stanley Says MT
04-01 Morgan Stanley Lowers Price Target on RH to $240 From $275, Keeps Overweight Rating MT
12-20 JPMorgan Cuts Price Target on RH to $225 From $275, Maintains Overweight Rating MT
12-12 Stifel Downgrades RH to Hold From Buy, Adjusts Price Target to $165 From $320 MT
02/10/25 William Blair Downgrades RH to Market Perform From Outperform MT
12/09/25 Telsey Advisory Downgrades RH to Market Perform From Outperform, Adjusts Pt to $220 From $255 MT
25/06/25 RH Shares Fall After Goldman Sachs Downgrade MT
24/06/25 Goldman Sachs Downgrades RH to Sell From Neutral, Adjusts Price Target to $179 From $199 MT
05/06/25 UBS Adjusts RH Price Target to $215 From $235, Maintains Neutral Rating MT
15/05/25 BofA Securities Adjusts Price Target on RH to $172 From $144 MT
08/04/25 RH Cash Flow, Demand Guidance Eases Tariff Concerns, Wedbush Says MT
03/04/25 RH Earnings Troubles Exacerbated by Trump Tariffs, Wedbush Says; Shares Down Pre-Bell MT
03/04/25 Wedbush Adjusts RH Price Target to $250 From $350, Maintains Outperform Rating MT
03/04/25 UBS Adjusts Price Target on RH to $235 From $250, Keeps Neutral Rating MT
27/03/25 RH Could See Solid Sales, Soft Margins for Fiscal Q4, Wedbush Says MT
26/03/25 BofA Securities Cuts RH Price Target to $410 From $510, Maintains Buy Rating MT
26/03/25 Wedbush Cuts Price Target on RH to $350 From $500, Keeps Outperform Rating MT
21/03/25 UBS Adjusts Price Target on RH to $250 From $440, Keeps Neutral Rating MT
30/01/25 Goldman Sachs Upgrades RH to Neutral From Sell, Raises Price Target to $374 From $261 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+8.39%
+1.49%
+37.31%
+28.2%
+10.87%
+11.28%
+37.02%
+25.06%
+4.86%
Average +18.28%
Weighted average by Cap. +10.21%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
121.19USD
Average target price
166.41USD
Spread / Average Target
+37.31%
High Price Target
258.00USD
Spread / Highest target
+112.89%
Low Price Target
81.00USD
Spread / Lowest Target
-33.16%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
-
ESG MSCI
-